View Details. Events you might like:. Health Seminar. Share this event.
Breast Cancer Detection Techniques: Issues and Challenges | SpringerLink
Health Party. Health Networking. Health Class. Save This Event Log in or sign up for Eventbrite to save events you're interested in. Sign Up. Already have an account? Log in.
Meet the scientists taking on 3 of the biggest challenges in cancer research
Event Saved. Your message has been sent!
Your email will only be seen by the event organizer. Several factors account for this disparity.
First, insurance is covering less. A year ago, among the general population of patients being treated for breast cancer, half reported their insurance covered most of the cost — between 75 percent and 90 percent — of their treatment. In , that number dropped to 40 percent.
- chapter and author info.
- Psyched For Bed With Nothing To Read (bedtime tales for the weary)?
- The Global Challenge to Prevent Breast Cancer;
- The costs of cancer?
A third of younger patients who have to quit work in order to get treatment find it difficult to find new jobs afterward. Just 16 percent of older patients said this was a problem. When patients are diagnosed younger, their treatment is likely to take longer. With no job to return to, younger women are especially harmed financially.
The top things you can do to protect yourself from medical financial harm are emergency savings and to know in advance what the cost of treatment will be. If possible, consult a financial navigator if your medical provider has one on staff.
There's no cost to the patient. Navigators help you understand what your out-of-pocket expenses might be and what your insurance plan covers. They can also find cost-saving treatments and improve access to health-care services. When families are in a health crisis and the patient goes into panic mode, it's very difficult to maintain good financial habits, MacDonald said. Sign up for free newsletters and get more CNBC delivered to your inbox. Get this delivered to your inbox, and more info about our products and services.
What is your transformative idea?
Data also provided by. Skip Navigation. Markets Pre-Markets U. World Economy read more. National Cancer Institute.
Surveillance, Epidemiology, and End Results Program. Accessed December 20, Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Descriptive analysis of estrogen receptor ER -negative, progesterone receptor PR -negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. The fate of chemoresistance in triple negative breast cancer. BBA Clin. American Cancer Society website.
Triple-negative breast cancer: treatment challenges and solutions
Breast cancer. Accessed November Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers. Ther Adv Med Oncol. Genes Cancer. Audeh MW. Novel treatment strategies in triple-negative breast cancer: specific role of poly adenosine diphosphate-ribose polymerase inhibition.
Pharmacogenomics Pers Med. Poly ADP-Ribose polymerase inhibition: "targeted" therapy for triple-negative breast cancer. Clin Cancer Res. Zhu Y, et al.